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Neuronal development is promoted by weakened
intrinsic antioxidant defences due to epigenetic
repression of Nrf2
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Forebrain neurons have weak intrinsic antioxidant defences compared with astrocytes, but
the molecular basis and purpose of this is poorly understood. We show that early in mouse
cortical neuronal development in vitro and in vivo, expression of the master-regulator
of antioxidant genes, transcription factor NF-E2-related-factor-2 (Nrf2), is repressed by
epigenetic inactivation of its promoter. Consequently, in contrast to astrocytes or young
neurons, maturing neurons possess negligible Nrf2-dependent antioxidant defences, and
exhibit no transcriptional responses to Nrf2 activators, or to ablation of Nrf2’s inhibitor Keap1.
Neuronal Nrf2 inactivation seems to be required for proper development: in maturing
neurons, ectopic Nrf2 expression inhibits neurite outgrowth and aborization, and electro-
physiological maturation, including synaptogenesis. These defects arise because Nrf2 activity
buffers neuronal redox status, inhibiting maturation processes dependent on redox-sensitive
JNK and Wnt pathways. Thus, developmental epigenetic Nrf2 repression weakens neuronal
antioxidant defences but is necessary to create an environment that supports neuronal
development.
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I
n isolation, neurons tend to be more vulnerable to oxidative
insults than astrocytes partly as a result of weaker antioxidant
defences resulting from lower levels of glutathione and
reduced catalase activity1,2. Astrocytic-derived extrinsic support
is known to play an important role in protecting neurons against
excessive reactive oxygen species (ROS) production3–5, which is
likely to be an important factor in maintaining neuronal viability
throughout an organisms lifetime. However, the molecular
mechanisms underlying these cell-type-speciﬁc differences in
antioxidant defences are unclear. Understanding the basis for the
low intrinsic antioxidant capacity of neurons may provide
therapeutic targets aimed at boosting their antioxidant defences
as a protective strategy against acute and chronic neurological
and neurodegenerative disorders associated with oxidative stress6.
The biological rationale for the relatively weak intrinsic
antioxidant defences of neurons is unknown. At face value, it
seems paradoxical that neurons should be endowed with
relatively weak antioxidant defences: not only do they generate
more ROS than most cell types because of high metabolic activity,
but also their post-mitotic and non-regenerative nature means
that they must survive for many years without being rendered
dysfunctional by accumulating oxidative damage. Forebrain
neurons receive signiﬁcant antioxidant support from surrounding
astrocytes4,5 (for example, via supply of precursors for
glutathione biosynthesis7), which is then utilized by neuronal
systems8, however, the reason why neurons have evolved to need
non-cell autonomous protection is unclear.
The transcription factor NF-E2-related factor 2 (Nrf2) is a
master regulator of antioxidant defences that controls a battery of
antioxidant and detoxiﬁcation genes containing cognate-binding
sites within their promoters (referred to as antioxidant response
elements, AREs)9. Nrf2 is widely thought to be ubiquitously
expressed and has been shown to protect cells against a variety of
stress-induced diseases, and become dysregulated in certain
cancers10,11. Basal levels of nuclear Nrf2 are normally quite low,
as it is targeted for ubiquitin-mediated degradation by its
inhibitor Keap1 in the cytoplasm. However, in response to
oxidative stress or small-molecule inhibitors of Keap1, Nrf2
accumulates and translocates to the nucleus where it activates a
battery of antioxidant and detoxiﬁcation genes11,12. Examples of
Nrf2 target genes include Catalase (Cat) and glutamate-cysteine-
ligase catalytic subunit (Gclc), which catalyses the rate-limiting
step of glutathione biosynthesis13–15. Activation of Nrf2-mediated
gene expression in astrocytes, either via overexpression or
pharmacological activation, confers non-cell autonomous
protection to surrounding neurons in a variety of models,
including rodent models of neurodegenerative disease, as well as
human stem cell-derived neuron-astrocyte systems7,16,17.
However, the neuronal Nrf2 pathway has been reported
to be weak4,5, although how and why this is the case, is not
well understood.
We show here that both basal and inducible Nrf2 activity in
cortical neurons is extremely low due to epigenetic repression of
the Nrf2 gene promoter early in development. Moreover, we show
that inactivation of the Nrf2 pathway provides a more ﬂexible
redox environment, which is crucial for key redox-sensitive
signalling pathways that mediate early neuronal development.
Collectively, our study provides both the molecular mechanism
and the biological reason behind the apparent paradox of weak
neuronal intrinsic antioxidant defences.
Results
Limited role for Nrf2 in neuronal antioxidant defenses. As
forebrain neurons have been reported to support lower basal and
induced Nrf2-dependent gene expression than astrocytes4,5,
we hypothesized that this may contribute to their differential
vulnerability to oxidative stress. We observed that cortical
neurons were more sensitive to an oxidative insult (H2O2) than
astrocytes but that, unlike astrocytes, Nrf2 deﬁciency did not alter
their vulnerability (Fig. 1a). Moreover, although neuronal
expression of Cat and Gclc, key antioxidant Nrf2 target genes,
was lower than in astrocytes (Fig. 1b), Nrf2 deﬁciency did not
affect their levels in neurons (Fig. 1c), but did in astrocytes
(Fig. 1d). Thus, in cortical neurons, basal Nrf2 activity does not
contribute to intrinsic antioxidant defences, partly explaining why
neuronal defences are weak compared with astrocytes.
Hypo-expression of Nrf2 in cortical neurons. Neither pharma-
cological activation of Nrf2 by tert-butyl hydroquinone (tBHQ),
nor genetic activation of Nrf2 by Keap1-knockout, triggered
induction of the Nrf2 target genes Hmox1, Srxn1 and xCT in
neurons (Fig. 1e–g). In contrast, astrocytes, either on their own or
in a mixed culture preparation (containing 90% neurons and 10%
astrocytes) supported robust pharmacological activation (Fig. 1e,f)
that was abolished in Nrf2–/– cultures (Supplementary Fig. 1a for
Hmox118, for xCT and Srxn1), as well as elevated Nrf2 target gene
expression in a Keap1-deﬁcient background (Fig. 1h,i). We also
performed experiments under 5% O2 conditions to eliminate the
possibility that the neuronal Nrf2 pathway was maximally induced
by ambient air conditions. However, unlike mixed astrocyte/
neuronal cultures, neuronal cultures showed no induction of Nrf2
target genes by tBHQ at 5% O2 (Fig. S1b).
Cortical neurons are therefore unable to mount signiﬁcant
Nrf2-mediated transcriptional responses, raising the question
about the mechanistic basis for this. Although Nrf2 protein is
dynamically regulated at the level of Keap1-mediated degrada-
tion, the fact that no gene induction was observed in Keap1–/–
neurons suggests the lack of a functional Nrf2 pathway is due to
pre-translational events. This concept is supported by our
observations that forced expression of Nrf2 in neurons induces
expression of Nrf2 target genes such as Srxn1 (ref. 19) and
Hmox1 (Supplementary Fig. 1c), resulting in the protection of
neurons against oxidative stress19 and oxygen-glucose
deprivation (Supplementary Fig. 1d). This suggests that Nrf2
target genes are amenable to activation in neurons when Nrf2 is
present, but that levels of endogenous neuronal Nrf2 are
insufﬁcient to mediate such induction. We therefore studied
neuronal Nrf2 mRNA expression and found it to be less than 2%
of that found in astrocytes (Fig. 1j) consistent with previous
observations4,5. Moreover, the increase in Nrf2 protein stimulated
in neurons by tBHQ or proteosomal inhibition is markedly lower
than in astrocytes or mixed neuronal-astrocyte cultures (Fig. 1k,l).
We wanted to determine whether hypo-expression of Nrf2 is
also a feature of neurons in vivo. Adult mouse cortices were
subjected to ﬂuorescence-activated cell sorting (FACS), using
a method that separates neurons from non-neurons based
on NeuN-positive immunoﬂuorescence, while preserving the
capacity to extract RNA20 (Supplementary Fig. 1e). As well as
predictable positive and negative enrichment for neuronal and
non-neuronal markers, NeuNþ cells were found to express very
low levels of Nrf2 (Fig. 1m), consistent with our in vitro
observations. We also investigated whether neuronal Nrf2 hypo-
expression is relevant to the human. Cortical-patterned neurons
and astrocytes were generated from the same human embryonic
stem cell (hESC) line (H9) as described previously17,21,22.
Strikingly, hESC-derived neurons expressed far less Nrf2 than
hESC-derived astrocytes (Fig. 1n, for comparison, GRIN1 showed
the reverse enrichment). Thus, in vitro, in vivo and in a model
human system, Nrf2 is severely underexpressed in neurons as
compared with astrocytes.
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Epigenetic repression of Nrf2 in developing neurons. We
hypothesized that the hypo-expression of Nrf2 in neurons could
be a result of epigenetic repression. Chromatin immunoprecipi-
tation (ChIP) analysis of acetylated histone H3 associated with
the Nrf2 promoter revealed a strong degree of hypo-acetylation in
neurons as compared with astrocytes (Fig. 2a left), whereas
no differences were found at the Beta-actin gene promoter
(Fig. 2a right). We next investigated whether Nrf2 promoter
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Figure 1 | The Nrf2 pathway is weak in cortical neurons. (a) Impact of Nrf2 deﬁciency on vulnerability to H2O2 treatment, in DIV10 astrocytes (498%
GFAPþ astrocytes) or neurons (cortical cultures containing 498% NeuNþ neurons, o0.02% GFAPþ astrocytes). Cells were treated with H2O2, ﬁxed
after 24 h, DAPI stained and scored for survival/death based on nuclear morphology. *Po0.05, Student’s t-test here and throughout unless otherwise
stated (neurons: n¼4, 700–2000 cells analysed per condition per genotype (PCPG); astrocytes wt n¼ 5, 700–2,000 cells PCPG, ko n¼ 7, 2,100–2,700
cells PCPG). Data are displayed as mean±s.e.m. throughout. (b) Nrf2 target genes Cat and Gclc expression analysed by qRT–PCR, normalized to 18s rRNA,
expressed relative to the level in pure neuronal cultures. Mixed cultures: approximately 10% GFAPþ astrocytes, 90% NeuNþ neurons. *Po0.05, Cat
n¼ 6, Gclc n¼ 7. (c,d) Impact of Nrf2 deﬁciency on Cat or Gclc mRNA expression in neurons (c) and astrocytes (d). *Po0.05 compared with wild type
(WT); Cat n¼4, Gclc n¼ 5. (e) qRT–PCR analysis of Nrf2 target gene (Hmox1, Srxn1 and xCT) expression in response to tBHQ (10 mM, 8 h) treatment of
neuronal or mixed cultures. *Po0.05 (n¼ 5–6). (f) Immunohistochemical analysis of Hmox1 expression in tBHQ-treated mixed cultures. *Po0.05 (n¼ 5).
Upper: example pictures illustrating elevation of Hmox1 in astrocytes within tBHQ-treated mixed cultures. Scale bar, 25mm. (g–i) The effect of Keap1
deﬁciency on Nrf2 target genes. *Po0.05 (compared with WTcontrol (Con), n¼8–15). (j) Nrf2 mRNA analysed in parallel cultures of the indicated types.
*Po0.05, (n¼ 10). (k) Western blot analysis of Nrf2 expression in different cell types treated with tBHQ (TB; 10mM) or MG132 (MG; 5 mM) for 16 h.
(l) Images of mixed cultures treated as indicated and stained with an anti-Nrf2 antibody (red) and a neuronal marker (Milli-Mark). White arrows highlight
lack of Nrf2 induction in neurons. Scale bar, 25 mm. (m) qRT–PCR analysis of Nrf2 and neuronal/non-neuronal marker gene expression in RNA isolated from
FAC-sorted adult cortical NeuNþ neurons, expressed relative to levels in NeuN cells. *Po0.05 (n¼4). See Supplementary Fig. 1e. (n) Expression of
NRF2 (NEF2L2) and GRIN1 analysed in astrocytes and neurons derived from H9 hESCs. *Po0.05 (n¼ 3). NS, not signiﬁcant.
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hypo-acetylation and transcriptional repression could be reversed
by inhibiting histone deacetylases. Treatment of neurons with the
ClassI/II histone deacetylase (HDAC) inhibitor trichostatin A
(TSA) boosted Nrf2 promoter H3 acetylation (Fig. 2b left),
without affecting H3 acetylation at the Beta-actin promoter
(Fig. 2b right), and resulted in increased Nrf2 expression (Fig. 2c),
an effect also observed in hESC-derived neurons (Fig. 2d). In
contrast, TSA did not increase Nrf2 expression in astrocytes of
mouse or hESC origin (Supplementary Fig. 2a,b). TSA adminis-
tration in vivo to adult mice also boosted Nrf2 expression in
NeuNþ (Fig. 2e) but not NeuN cortical cells (Supplementary
Fig. 2c). Thus, neuronal Nrf2 is amenable to derepression by
HDAC inhibition in vitro, in vivo and in human neurons. This
raised the question as to whether neuronal responsiveness to Nrf2
activators could also be restored. Indeed, the Nrf2 target gene
Srxn1 was induced by tBHQ treatment in neurons that had been
pre-treated with TSA (Fig. 2f). Thus, epigenetic repression of the
Nrf2 promoter is a major reason why there is an absence of a
functional Keap1-Nrf2 pathway in neurons, and reactivation of
the pathway by HDAC inhibition is achievable.
Neuronal Nrf2 repression is developmentally regulated. As
Nrf2 is widely considered to be ubiquitously expressed, its
repression in neurons is unusual, raising the question as to
whether the Nrf2 shut-off might be mapped to a speciﬁc devel-
opmental window. We observed that highly immature 2 days in
vitro-DIV2 neurons expressed high levels of Nrf2 mRNA,
compared with DIV9 (Fig. 3a). In vivo, P0 FAC-sorted NeuNþ
and NeuN cells expressed similar amounts of Nrf2 mRNA
(Fig. 3b). As Nrf2 mRNA levels overall (in total cortical homo-
genate) were found to greatly exceed those in the P0 cortex than
in the adult (Fig. 3c), it is apparent that P0 cortical neurons
express high levels of Nrf2 in vivo, as compared with adult
neurons. Moreover, in our hESC system, we compared Nrf2
mRNA levels in hESC-derived cortical-patterned neurons with
those in their direct precursors (hESC-derived neural precursor
cells (NPCs)) as well as undifferentiated hESCs. We found Nrf2
mRNA levels are similar in undifferentiated hESCs, hESC-derived
NPCs and, indeed, hESC-derived astrocytes (Fig. 3d). Only when
NPCs are allowed to differentiate to neurons do levels of Nrf2
markedly decline (Fig. 3d). Thus, in vitro, in vivo and in a human
stem cell-based system, neuronal Nrf2 expression becomes
repressed during a developmental window early in neuronal
commitment. The epigenetic repression of Nrf2 described in
Fig. 2 takes place during the early stages of development. In
agreement with this hypothesis, ChIP studies revealed a devel-
opmental drop in Nrf2 promoter histone H3 acetylation between
DIV2 and DIV9 in neurons (Fig. 3e). Moreover, and in contrast
to DIV9 neurons, TSA treatment of DIV2 neurons did not result
in increased Nrf2 expression (Fig. 3f), indicative of a relatively
active, unrepressed promoter at this developmental stage.
The developmental shut-off of Nrf2 expression is also
associated with reduced expression of the Nrf2 target genes
Hmox1, Srxn1, xCt, Cat and Gclc (Fig. 3g), strongly suggesting
that very early in development, the Nrf2 pathway in neurons is
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Figure 2 | The Nrf2 promoter is epigenetically repressed in cortical neurons. (a) ChIP analysis of acetylated histone H3 (Ac-H3) occupancy at the Nrf2
(left) and b-actin (right) promoters in neurons and astrocytes, normalized to input and expressed relative to each other. *Po0.05, NS¼ no signiﬁcant
difference (n¼ 5). (b) Effect of TSA treatment (8 h) on Ac-H3 levels at the Nrf2 and b-actin promoters in neurons. *Po0.05 (n¼ 5). (c,d) Effect of TSA
treatment on Nrf2 expression in mouse cortical neurons (c) and human H9 ESC-derived neurons (d), normalized to Rpl13a. *Po0.05 (n¼ 3).
(e) Adult mice were subjected to intra-peritoneal injection of TSA (10mg kg 1) or vehicle (Veh.) and at 8 h culled and cortical neurons obtained by
enzymic dissociation of the cortex followed by FAC-sorting of NeuNþ cells. RNA was extracted immediately and Nrf2 expression studied. *Po0.05, (n¼ 7
(Veh.), 4 (TSA)). (f) Pre-treating cultured cortical neurons with TSA renders the neuronal Nrf2 pathway amenable to activation by tBHQ. Neurons were
treated as indicated in the schematic, and expression of Nrf2 and Nrf2 target gene Srxn1 analysed by qRT–PCR. (Po0.05 analysis of variance plus Tukey’s
post-hoc test, *signiﬁcant difference compared with control untreated cells; #signiﬁcant effect of tBHQþTSA compared with TSA alone condition). ‘NS’
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actually functional. Indeed, we found this to be the case:
induction of Nrf2 target genes in response to tBHQ treatment
was observed in Nrf2þ /þ DIV2 neurons but not in DIV2 Nrf2–/–
neurons (Fig. 3h). Moreover, further comparison of Nrf2þ /þ
and Nrf2–/– neurons at DIV2 revealed that basal Nrf2 activity
supported Cat and Gclc expression (Fig. 3i), and that Nrf2–/–
neurons showed a modest increase in vulnerability to oxidative
insults (Fig. 3j). Thus, very young neurons possess a functional
Nrf2 pathway that contributes to their intrinsic antioxidant
defences, which becomes lost during maturation.
Nrf2 antagonizes maturation of developing cortical neurons.
To investigate the biological purpose served by the developmental
silencing of neuronal Nrf2, we studied the impact of forced
expression of Nrf2 during the developmental period in which it is
ordinarily shut-off (Fig. 4a). Expression of Nrf2 at DIV4 resulted
in impaired dendritic outgrowth and arborization, assayed at
DIV7 by Sholl analysis, and by measuring total dendritic length
and total dendritic branch tip number (Fig. 4b–e). A comparison
of these properties with DIV4 neurons revealed that dendritic
branching, which normally increases strongly during this
developmental window (a threefold increase in branch number
over this period), is halted by the forced expression of Nrf2
(Fig. 4e). We also studied postsynaptic density protein 95
(PSD-95) puncta, by expressing a YFP-PSD-95 fusion construct
to label potential sites of nascent synaptogenesis, and found that
forced Nrf2 expression diminished PSD-95 puncta density
(Fig. 4f,g), further indicating an impairment of neuronal devel-
opment and maturation. We also examined the inﬂuence of
forced Nrf2 expression on the electrophysiological maturation of
developing neurons between DIV4 and DIV7, a period where
resting membrane potential hyperpolarizes (Fig. 4h) and action
potential (AP) amplitude increases (Fig. 4i,j), together with an
increase in the amplitude of a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR) mediated currents
(Fig. 4k). Strikingly, we found that all of these developmental
changes were strongly retarded by ectopic Nrf2 expression
(Fig. 4h–k). Interestingly, not all developmental processes were
equally affected: in particular, AMPAR-mediated currents were
affected strongly (both net currents and current density (current/
capacitance), Fig. 4k, Supplementary Fig. 3), and far more than
N-methyl-D-aspartate receptor (NMDAR)-mediated currents.
This resulted in a twofold reduction in AMPAR/NMDAR ratio,
lower than that observed at either DIV7 or DIV4 (Fig. 4l). We
next wanted to ascertain the impact of forced Nrf2 expression on
synaptic currents. To study this we transfected neurons at DIV4
as before, but recorded from them at a later developmental stage
(DIV17) to allow further synaptic maturation within the network.
We ﬁrst conﬁrmed by immunoﬂuorescence that Nrf2 was still
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vehicle or tBHQ suggests a functional Nrf2 pathway at this stage. *Po0.05 (n¼ 5 (wild type (WT)), 4 (knockout (KO)). (i) Analysis of Cat and Gclc
expression in Nrf2þ /þ and Nrf2 / DIV2 neurons. *Po0.05 (n¼ 5 (WT), 4 (KO)). (j) Quantiﬁcation of H2O2-induced cell death in Nrf2þ /þ and
Nrf2 / DIV2 neurons. *Po0.05 (n¼4, 1,700–4,500 cells analysed per condition per genotype).
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expressed from the plasmid at DIV17 (data not shown) and that
AMPAR current and current density were reduced
(Supplementary Fig. 3b,c), as is the case at DIV7 (Fig. 4k and
Supplementary Fig. 3a). To assess the magnitude of synaptic
activity, we measured the average charge transfer during a
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Figure 4 | Forced Nrf2 expression in young neurons impairs development. (a) Schematic demonstrating the experimental timeline. Neurons were
developmentally assessed (either morphologically or electrophysiologically) on DIV7 or DIV17 (for synaptic activity). For baseline DIV4 neuronal morphology
and electrophysiological properties, neurons were transfected on DIV3 and assessed 24h later. (b) Example images of transfected neurons on either DIV7 or
DIV4 as indicated. Scale bar, 50mm. (c) Sholl analysis of dendritic morphology of control (DIV4 and DIV7) and Nrf2-transfected (DIV7) neurons. Two-way
analysis of variance plus Tukey’s post-hoc test here and throughout the ﬁgure. *Po0.05 compared with DIV7 (control (Con)); #Po0.05 compared with DIV4
(Con); 40–48 neurons analysed per condition within n¼4 independent experiments. (d,e) Dendritic length (d) and branch tip number (e) were analysed in
the population of neurons studied in c. *Po0.05 (n¼4). (f) Example images of PDS-95 puncta in DIV8 neurons transfected with YFP-tagged PSD-95 plus
either a plasmid encoding Nrf2 (pNrf2) or control plasmid on DIV4 (scale bar, 10mm). (g) Quantiﬁcation of f showing a reduction in PSD-95 density in pNrf2-
transfected DIV8 neurons (*Po0.05, dendrites from 24 to 30 neurons were studied for each condition within n¼ 3 independent experiments). (h) Neuronal
Nrf2 expression between DIV4–7 causes a signiﬁcant change in resting membrane potential, as compared with controls (*Po0.05, n¼ 11,9,7). (i) Example
whole-cell current-clamp traces of evoked action potentials (APs) recorded from neurons transfected as indicated. (j) Quantiﬁcation of AP amplitude in
neurons transfected as indicated (*Po0.05, n¼9,9,8). (k) AMPA receptor currents measured in DIV7 and DIV4 neurons transfected as indicated (*Po0.05,
n¼ 11,10,8). (l) The AMPA/NMDA ratio was calculated in neurons expressing pNrf2 as compared with control plasmid (Po0.05, n¼ 11,10,8). (m) Neurons
were transfected with either control plasmid or pNrf2, plus an eGFP co-transfection marker on DIV4. On DIV17, EPSCs were recorded over a 5-min period and
the average charge transfer (pQ) calculated. *Po0.05 (n¼ 8). Example traces are shown to the right. Scale bar, 500pA, 500ms. (n) mEPSC frequency
measured in neurons transfected as indicated on DIV4 and recorded on DIV17. *Po0.05 (n¼9 control, n¼ 8 Nrf2).
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(EPSCs), and found that in Nrf2-expressing cells the EPSC size
was far lower than in control-transfected neurons (Fig. 4m),
consistent with there being fewer functional synapses. In addition,
we analysed the inﬂuence of spontaneous tetrodotoxin-insensitive
miniature EPCSs (mEPSCs). mEPSC frequency offers a func-
tional measure of synapse number. We found that Nrf2 expres-
sion caused a strong reduction in mEPSC frequency (Fig. 4n) but
not size (Supplementary Fig. 3j), consistent with there being fewer
functional synapses, in agreement with the YFP-PSD-95 data
(Fig. 4g) and the tetrodotoxin-sensitive synaptic EPSC results
(Fig. 4m). Collectively, these data provide functional evidence
that synaptic development is retarded by Nrf2.
Next we investigated whether forced expression of Nrf2 in
more mature neurons that are developing less rapidly may be less
deleterious to neuronal function. We investigated the inﬂuence of
Nrf2 expression between DIV14 and 17, which provides a 3-day
expression window similar to the DIV4–7 window used in the
earlier assessments. In contrast to DIV4–7, when AMPAR
currents are increasing dramatically (Fig. 4k), AMPAR currents
have stabilized by DIV14 (Supplementary Fig. 3d). Interestingly,
we found that Nrf2 expression during DIV14–17 did not
inﬂuence AMPAR currents (Supplementary Fig. 3e, expression
of Nrf2 was conﬁrmed (data not shown)). Dendritic analysis is
problematic at DIV17 due to extensive, overlapping processes
from neighbouring transfected cells. However, measurement of
membrane capacitance provides a surrogate measure of mem-
brane area (and therefore outgrowth). Consistent with the
dendrite analysis data (Fig. 4b–e), membrane capacitance
increases sharply between DIV4 and 7, and this increase is
inhibited by Nrf2 (Supplementary Fig. 3f). In contrast, membrane
capacitance is stable between DIV14 and 17 (Supplementary
Fig. 3g) and Nrf2 expression between DIV14 and 17 has no effect
compared with control-transfected neurons (Supplementary
Fig. 3h). Of note, Nrf2 expression over an extended window
(DIV4–17) does reduce membrane capacitance (Supplementary
Fig. 3i), just as it impairs synaptic maturation (Fig. 4m).
Collectively, these data indicate that forced expression of Nrf2
in neurons early in differentiation (around DIV4) at a time when
it is normally subject to repression is deleterious to their
development. These developmental defects become apparent
quickly (by DIV7), potentially because growth and electrophy-
siological maturation is rapid at this stage. Moreover, these
defects are still observed later on (DIV17) so long as Nrf2
expression is initiated early, but not if expression is initiated later
in development (DIV14). We suggest that downregulation of
Nrf2 early in development might help establish a redox
environment, which is permissive for signalling pathways
involved in neuronal maturation during a critical developmental
window over which particularly rapid electrical and morpholo-
gical maturation takes place.
Developmentally important pathways are repressed by Nrf2.
The Wnt signalling pathway plays a key role in neuronal differ-
entiation23; both canonical (via b-catenin) and non-canonical
(via Rac and JNK) Wnt signalling contribute to dendritic
development and synaptogenesis24,25. Consistent with this, we
found dominant negative mutants of b-catenin (b-cat-ARM-
Myc) or Rac (Rac-N17) interfered with dendritic development
(Fig. 5a–c), with Rac-N17 having a considerably stronger effect
(Fig. 5a–c). The highly speciﬁc peptide inhibitor D-JNKI-1 also
impaired dendritic outgrowth and arborization (Fig. 5e–g).
PSD-95 clustering was also impaired by interfering with
b-catenin, Rac or JNK (Fig. 5d,h). In addition, expression of
Rac-N17, or JNK inhibition, also resulted in lower AMPAR
currents (Supplementary Fig. 4a). Thus, cortical neuronal
development is impaired by inhibition of Rac and JNK,
mediators of non-canonical Wnt signalling, as well as via the
interference of canonical Wnt signalling via inhibition of
b-catenin, consistent with previous ﬁndings in hippocampal
neurons23–25.
The Wnt pathway is known to be sensitive to cellular redox
status, and can be potentiated by ROS (H2O2) at least in part via
inactivation of the Dishevelled (Dvl) inhibitor nucleoredoxin
(Nrx), which is redox-sensitive26. However, Wnt pathway
regulation by ROS in neurons is not well-studied. Moreover, a
recent study demonstrated that ROS generation is important for
Wnt-dependent differentiation in a neural progenitor cell line, as
well as for the dissociation of Nrx from Dvl27. To investigate
potential redox regulation of Wnt signalling in cortical neurons,
we used a mixed culture preparation (90% neurons, 10%
astrocytes) in which doses of up to 50 mM H2O2 were not
neuro-toxic, and a transfection protocol that overwhelmingly
targets neurons over astrocytes28. We found that mild sub-toxic
doses of H2O2 potentiated Wnt signalling as assayed by
measuring b-catenin-dependent TCF/LEF-luciferase reporter
activity (M50 Super 8x TOPFlash b-catenin reporter, Fig. 5i,j).
It seems likely that Nrx is involved in this potentiation because
Nrx-directed short hairpin RNA (shRNA) both increased basal
Wnt pathway activity and partly occluded the potentiating effect
of mild sub-toxic doses of H2O2 (Fig. 5i). Forced expression of
Nrf2 both lowered basal Wnt reporter activity, and abolished its
potentiation by H2O2 treatment (Fig. 5j). We also observed that
the same low H2O2 conditions that boosted Wnt signalling also
served to activate JNK signalling, again in a manner inhibited by
Nrf2 expression (Fig. 5k,l). It should be recognized, however, that
JNK also has other redox-sensitive upstream activators such as
ASK1. Nevertheless, these data show that developmentally
important signalling pathways are sensitive to the redox status
of maturing neurons, and are inhibited by ectopic Nrf2. This
suggests that Nrf2 expression boosts antioxidant levels to such a
point that low ROS levels are unable to activate redox-sensitive
signalling pathways because they are rapidly inactivated in the
cell. To visualize this directly, we employed the Grx1-roGFP
genetically encoded reporter of cellular redox potential, Grx1-
roGFP229, which is highly sensitive to small ﬂuctuations in redox
potential29. Small doses of H2O2 produced strong ﬂuctuations in
the probe signal (Fig. 5m,n, Supplementary Fig. 4c). In Nrf2-
expressing neurons, the same doses of H2O2 elicited far weaker
responses, conclusively showing that Nrf2 expression boosts the
capacity of neurons to buffer their redox potential, providing an
explanation for Nrf2’s inhibitory effects on H2O2-induced
activation of JNK and Wnt signalling.
Collectively, these observations raise the possibility that the
effects of Nrf2 expression during development are partly due to
interference with Wnt-dependent development, the importance
of which we have conﬁrmed above. To investigate this we tested
whether either dominant-negative b-cat-ARM or Rac-N17
expression had any inﬂuence on neuronal development against
a background of forced Nrf2 expression, focusing on dendritic
outgrowth and arborization. We found that the effect of either
dominant-negative b-cat-ARM or Rac-N17 on dendritic arbor-
ization were entirely non-additive to the effects of Nrf2
expression (Fig. 6a–c and Fig. 6d–f, respectively). This is
suggestive of a common pathway: that is, that the effects of
forced Nrf2 expression are due in part to Wnt pathway inhibition.
Furthermore, these data also suggest that a key reason for
Nrf2 shut-off during development is to allow Wnt-dependent
development and maturation processes to take place.
Rescue of developmental deﬁcits induced by Nrf2. Finally, we
investigated whether the deleterious effects of Nrf2 expression on
dendritic outgrowth and arborization could be rescued by
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artiﬁcially activating canonical and non-canonical Wnt signalling
or JNK. We found that expression of both a constitutively active
form of b-catenin (b-catenin-S33Y, Fig. 6g–j) or Rac (Rac1-Q61L,
Fig. 6k–n) or overexpression of JNK1 (Jnk/1a, Fig. 6o–r) partly
rescued neurons from the morphological deﬁcits caused by Nrf2
expression. Nrf2 expression was not affected (Supplementary
Fig. 4e). Nrx shRNA also partly rescued dendritic length, but not
branch tip number (Supplementary Fig. 4f). Collectively, these
data support a model whereby Nrf2-driven antioxidant defences
repress the activity of redox-sensitive Wnt and JNK pathways,
leading to deﬁcits in neuronal development. They also offer a
biological reason behind the developmental epigenetic shut-off of
the Nrf2 promoter: by slightly weakening neurons’ intrinsic
antioxidant defences via Nrf2 inactivation, a more permissive
environment is provided for redox-sensitive signalling pathways
critical for neuronal development.
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Discussion
We have shown that Nrf2 expression is shut-off during neuronal
development, contributing to weakened antioxidant defences, and
have provided an explanation for the paradoxical inactivation of
this cytoprotective pathway by demonstrating the inhibitory
effect of Nrf2 on key developmental processes and pathways.
Cellular antioxidant defences must be carefully tuned to the
requirements of the cell. Not only does the redox potential of the
cell need to be appropriate for the stability of proteins and other
molecules, but also the redox buffering capacity of the cell must
strike a balance between limiting excessive ROS levels, while
allowing redox signalling for physiological processes30. In the
latter case, there is evidence that redox signalling directs
differentiation and development in the nervous system and
elsewhere. Mitochondrially derived ROS are important for
adipocyte differentiation31 and are involved in promoting the
oxidation of Nrx and activation of Wnt-dependent epidermal
differentiation and hair follicle development32. Interestingly,
ectopic expression of the Drosophila Nrf2 homologue CncC in
the compound eye causes a rough-eye phenotype33, consistent
with excessive Nrf2-induced activity being deleterious for normal
differentiation and development.
There is growing evidence supporting a role for ROS in
promoting neurogenesis and neuronal differentiation34–36.
Differentiation of PC12 cells, Neuro2a cells, the human neural
progenitor ReNcell VM197 line and also of rat cortical precursors
is associated with ROS generation and is affected by antioxidant
treatment27,34,36. Mechanistically, a link between ROS signalling
and JNK-dependent synapse development has been demonstrated
in the context of Drosophila neuromuscular junction
development37. Moreover, it is apparent that physiologically
appropriate levels of ROS must be maintained, as excessive
oxidative stress can cause synapse overgrowth37. In addition to
synaptic growth, JNK plays roles in dendritic arborization and
axon formation, in part by controlling microtubule dynamics38.
As a downstream effector of non-canonical Wnt signalling as well
as redox-sensitive upstream activators such as ASK1, JNK is
potentially regulatable by ﬂuctuations in cellular redox potential
via a variety of mechanisms. Wnt signalling is another
developmental pathway potentiated by mild ROS exposure26,27.
In neurons, Wnt signalling directs progenitor differentiation,
dendritic development and synaptogenesis23–25,27 via both
canonical and non-canonical pathways. Moreover, Rac, part
of the non-canonical pathway, promotes AMPAR clustering and
excitatory neurotransmission39. Our study indicates that these
and potentially other pathways are inhibited by Nrf2-mediated
gene expression in developing neurons, providing a biological
reason behind the developmental shut-off of Nrf2 expression.
Our working hypothesis is that Nrf2-directed antioxidant gene
expression limits redox ﬂuctuations that help to potentiate redox-
sensitive signalling pathways. Two recent studies have shed light
on the possible sources of these redox ﬂuctuations. Bursts of
mitochondrial superoxide production, mediated by transient
mitochondrial permeability transition pore opening and caused
by Ca2þ signals, have been implicated in promoting ROS-
dependent neural progenitor differentiation36. The key trigger for
this may be mitochondrial Ca2þ uptake, which has been shown
to be critical for mitochondrial ROS production and ROS-
dependent neural progenitor differentiation in a separate study27.
However, beyond redox control of key redox-sensitive signalling
pathways, it remains possible that Nrf2 may control the
expression of genes that directly interfere with neuronal
differentiation.
Activation of Nrf2-mediated transcription in astrocytes, either
via forced Nrf2 expression or treatment with small-molecule
Keap1 inhibitors, confers protection on nearby neurons4,7,40. This
involves the production and release of astrocytic glutathione4, a
process that is conserved in human stem cell-derived astrocytes41.
Astrocytic Nrf2 is able to ameliorate pathology in models of a
variety of neurodegenerative diseases, including ALS and
Parkinson’s disease7,16,40,42. It had been reported, using an
ARE-reporter gene that neurons respond less well to Nrf2
activators than astrocytes, the basis for which was unclear4. This
ﬁnding is consistent with our observations that neither
pharmacological inducers of Nrf2 nor genetic ablation of Keap1
can induce Nrf2-mediated responses in cortical neurons, because
of the transcriptional repression of the Nrf2 gene itself. Our work
also demonstrates that Nrf2 repression is also a feature of neurons
in vivo (using acute FAC-sorting) and in neurons derived from
hESCs. Mechanistically, we showed that histone H3 associated
with the Nrf2 gene promoter becomes hypo-acetylated during
development, resulting in transcriptional repression. However,
Class I/II HDAC inhibition resulted in only partial derepression
of Nrf2, suggestive of additional repression mechanisms.
Interestingly, the polycomb group protein EZH2, a histone H3
Lys27 (H3K27) trimethyltransferase, was recently identiﬁed as a
negative regulator of Nrf2 expression in lung epithelial cells,
raising the possibility that this may contribute to Nrf2 repression
in neurons. The potential role of Class III HDACs remains to be
explored.
Activation of Nrf2 by mild oxidative stress is a classical
cytoprotective response that enables antioxidant defences to be
boosted under conditions of demand11. The shut-off of Nrf2 in
maturing neurons means that this route is either unavailable to
Figure 5 | Nrf2 inhibits redox-sensitive neuronal developmental signalling pathways. (a) Sholl analysis of neurons transfected DIV4–7 with DN-bCat:
bcat ARM-Myc; Rac-N17: Rac N17-Myc. *Po0.05 compared with control (Con): two-way analysis of variance (ANOVA) plus Dunnett’s post-hoc, n¼ 3, 24
cells per condition. (b,c) Total dendritic length (b) and branch tip number (c) calculated for the cells analysed in a. *Po0.05, one-way ANOVA plus
Dunnett’s post-hoc. (d) YFP-PSD-95 puncta density measured. *Po0.05, n¼4 (32–40 cells quantiﬁed per condition). Example pictures to the right (scale
bar, 10 mm). (e) Sholl analysis of neurons treated daily±D-JNKI1 (2mM) DIV4–6. *Po0.05, two-way ANOVA plus Sidak’s post-hoc, n¼4 (40 cells per
treatment). (f,g) Dendritic length (f) and branch tip number (g) measured in the cells treated as in e. *Po0.05 Student’s t-test, n¼4 (20 cells per
treatment). (h) YFP-PSD-95 puncta density measured. *Po0.05 (n¼ 3, 24 cells per condition). Example pictures to the right (scale bar, 10mm).
(i) Neurons were transfected with a TCF/LEF-luciferase reporter of Wnt signalling, a pTK-renilla Con, Dvl1 plasmid, plus Con or Nrx-directed shRNA vector
(ratio: 2:1:2:2). 48 h post-transfection, neurons were treated with H2O2 for 16 h, and reporter activity measured (normalized to Renilla). *Po0.05, n¼ 3:
two-way ANOVA with Bonferroni’s post-hoc test here and for j. #Difference between H2O2-stimulated values and the corresponding Con. (j) Neurons were
transfected with the Wnt reporter, Renilla, Dvl1 plasmid, plus Con or Nrf2 vectors (ratio: 2:1:2:2). H2O2-induced Wnt activity measured as for i. *Po0.05,
n¼4. (k) Western analysis of H2O2 (25mM)-induced c-Jun (Ser-73) phosphorylation±D-JNKI-1 (DJI) pretreatment. *Po0.05 (n¼ 3). (l) Western
analysis of H2O2-induced c-Jun (Ser-73) phosphorylation in neurons nucleofected with Con or Nrf2-encoding plasmids. *Po0.05, two-tailed t-test (n¼ 3).
(m,n) Nrf2 activity buffers neuronal redox potential. Neurons expressing Grx1-roGFP plus either Con (globin) or Nrf2-encoding plasmids were imaged
during H2O2 treatment. Ratios (ex¼ 387±5 and 494±10; em¼ 530±10 in both cases) for each cell were calculated and normalized to the maximal ratio
obtained by treating cells with high H2O2 (100mM). *Po0.05, two-way ANOVA, plus Bonferronni’s post-hoc, n¼ 6 (30 (Con) and 35 (Nrf2) cells
analysed). (n) Example traces of single experiments relating to m.
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neurons, or of limited relevance. However, other adaptive
strategies exist to help match antioxidant capacity to oxidant
exposure. Mild oxidative stress, and sublethal episodes of
ischaemia in vitro and in vivo can activate Nrf2-dependent gene
expression in astrocytes, which contribute to neuroprotective
preconditioning in vitro43,44. Synaptic activity, an energetically
expensive process that places metabolic demands on the cell
and increases ROS production45 also triggers the expression of
antioxidant genes, boosting intrinsic antioxidant defences28,46,
including that of the glutathione (GSH) system47. Of note, some
of these genes are known Nrf2 target genes but are induced in
neurons via Nrf2-independent mechanisms involving factors AP-
1 and ATF4 (refs 18,28,48). Moreover, neuronal activity has
recently been reported to increase Nrf2 protein accumulation in
astrocytes49. In addition, other neuroprotective transcription
factors may help to compensate for Nrf2’s repression, including
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Figure 6 | Activation of the JNK or Wnt pathways rescues detrimental Nrf2-dependent alterations in neuronal maturation. (a–f) Expression of Nrf2
occludes the deleterious effects of DN-bCat or Rac-N17 on neuronal development. Neurons were transfected on DIV4 with the indicated plasmids, plus
GFP to visualize the cells, and studied at DIV7. Where used, quantities of DN-bCat, Rac-N17 and Nrf2 were always kept constant, and control plasmid used
to ensure that total quantity of transfected DNA was also constant. (a,d) Sholl analysis of neurons transfected as indicated. *Po0.05, two-way analysis of
variance (ANOVA), plus Tukey’s post-hoc test: *indicates difference between equivalent ‘Con’ and ‘Nrf2’ conditions. 15–24 cells analysed within n¼ 3
independent experiments. Note that the same ‘Con’ and ‘Nrf2’ conditions are shown for a and d because the DN-bCat and Rac-N17 experiments were
performed at the same time, with the data separated for easier visualization. (b,c,e,f) Dendrite length (b,e) and branch tip number (c,f) were calculated in
neurons transfected with the indicated plasmids. *Po0.05, two-way ANOVA with Tukey’s post-hoc test; 15–24 cells analysed per condition within n¼ 3
experiments. (g–r) Activation of Wnt, JNK or Rac signalling rescues the detrimental impact of Nrf2 expression on neuronal morphology. DIV4 neurons
were transfected with the indicated plasmids and Sholl, dendritic length and branch tip analysis performed as previously. (g,k,o) Sholl analysis: *Po0.05,
two-way ANOVA with Bonferronni’s post-hoc test. *A signiﬁcant rescue, comparing the Nrf2 only condition to Nrf2þbCatS33Y or RacQ61L, or JNK1a
(n¼4, 32–36 cells analysed in total per condition). (h,i,l,m,p,q) *Po0.05, one-way ANOVA with Dunnett’s post-hoc test (n¼4, 32–36 cells analysed in
total per condition). (j,n,r) Example images of neurons analysed. Scale bar, 50mm.
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nuclear factor-kB, whose activity increases during neuronal
maturation and which controls anti-apoptotic gene expression
as well as MnSOD50–52. These and other mechanisms may have
evolved to help mitigate the effects of low Nrf2 expression in
neurons.
Another important question is whether (re)activation of the
Nrf2 pathway in mature neurons offers a viable neuroprotective
strategy. In the context of antioxidant defences, Nrf2 activation in
neurons is likely to be beneﬁcial, rendering neurons resistant to
oxidative insults as well as ischaemic-like conditions in vitro.
Moreover, we observed that forced Nrf2 expression retarded
neuronal development DIV4–7 but not when initiated over a later
time window (DIV14–17). Nevertheless, further investigations are
required (and planned) to determine whether prolonged Nrf2
activation in mature neurons would have deleterious functional
consequences. In addition to being involved in synaptogenesis,
the Wnt pathway has recently been implicated in synapse
maintenance53, raising the possibility that perturbations that
interfere with this pathway may functionally compromise mature
neurons. If this were the case, then the continued repression of
Nrf2 in mature neurons could be desirable, so that transcriptional
responses in the brain to Nrf2-activating drugs are preferentially
induced in non-neuronal cells. Alternatively, it could be that Nrf2
repression is needed only very early in development during a
period of particularly rapid electrical and morphological
maturation. One can speculate that during this early period,
redox signalling is important for potentiating and maximizing the
strength of developmental signalling pathways. However, in
mature neurons there may not be a need for such a potentiation,
and lower levels of pathway activity (for example, to sustain
synapse maintenance) may sufﬁce. If this is the case, then
derepression of the neuronal Nrf2 promoter could be a promising
therapeutic strategy for brain disorders associated with oxidative
stress.
The data presented here suggests that derepression of the Nrf2
promoter by HDAC inhibition may render the neuronal Nrf2
pathway partly activatable by classical inducers, which block the
actions of Keap1. Interestingly, while classical inducers such as
tBHQ fail to induce a signiﬁcant response in neurons, the enone-
type electrophilic compound curcumin and its corresponding
dienone, NEPP11 have been reported to activate Nrf2 target gene
expression directly in neurons54,55. Of note, curcumin is known
to inhibit Class I HDACs and DNA methylation (as well as
being an activator of Nrf2 via blocking its Keap1-mediated
degradation), raising the possibility that its action involves both
derepression of the Nrf2 promoter and inhibition of Keap1-
mediated protein degradation. Regardless, to fully derepress Nrf2,
further research is necessary to uncover the molecular mechanism
of its developmental repression. Neuron-speciﬁc chromatin
remodelling and other epigenetic changes are known to be
important for development56,57, so it is possible that Nrf2 is a
target for these pathways. For example, Brg1/hBrm-Associated
Factor (BAF) chromatin remodelling complexes are capable of
both gene activation and repression, depending on their
composition, and neuron-speciﬁc BAF complexes are critical
for dendritic outgrowth and synaptogenesis57.
Of course, even if Nrf2 expression in neurons is derepressed, it
still needs to be activated by an appropriate small molecule to
mediate a response. Although several Nrf2-activating molecules
have demonstrated efﬁcacy in a variety of preclinical animal
models of brain disease, BG-12 (dimethyl fumarate) has emerged
as a particularly promising agent. BG-12 is a cytoprotective
compound licensed for relapsing remitting multiple sclerosis,
which activates Nrf2-mediated gene expression and has a
mechanism of action (at least in animal models) that is dependent
on Nrf2 (refs 58,59). Alternatively, it could be that in targeting
Nrf2 in neurons a balance might be struck between boosting the
Nrf2 pathway while preventing an overloading of excessive redox-
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buffering enzymes, or in only targeting those cells that are
stressed and in need of antioxidant support. To this end, the
development of so-called ‘pathologically activated therapeutics’ in
which oxidative stress modiﬁes a pro-drug to become a functional
Nrf2 activator may offer a promising strategy to activate Nrf2
only where it is needed60.
To conclude, the striking shut-down of the powerful Nrf2
cytoprotective pathway in neurons explains both the relative
vulnerability of neurons to oxidative stress and their reliance on
astrocytic support, but appears to be necessary for proper
neuronal development.
Methods
Cell culture. Cortical cells were cultured from E17.5 CD1 mouse embryos, Nrf2–/–
and wild-type embryos (c57Blk/6), and Keap-1–/– and wild-type embryos, essen-
tially as previously described61,62. Brieﬂy, cortices were dissociated in papain for
2 20min and plated at a density of between 9 and 13 104 neurons per cm2.
Three cell culture types were prepared: mixed28 neuronal/astrocyte cultures (90%
NeuNþ neurons and 10% GFAPþ astrocytes), highly enriched neuronal43 cultures
(498% NeuNþ neurons and o0.2% GFAPþ astrocytes) and highly enriched
astrocyte28 cultures (496% GFAPþ astrocytes). Mixed neuronal/astrocyte
cultures and highly enriched neuronal cultures were prepared in Neurobasal
growth medium plus 1% rat serum (Harlan Laboratories), B27 (Life Technologies
Ltd), 1mM glutamine and 1 antibiotic/antimycotic (Life Technologies Ltd),
whereas astrocyte cultures were obtained by plating cells at low density in
DMEMþ 10% Fetal Bovine Serum and 1 antibiotic/antimycotic (all Life
Technologies Ltd). To prevent astrocyte proliferation in neuron-containing
cultures, the anti-mitotic drug Cytosine b-D-arabino- furanoside hydrochloride
(1.2mM) was applied either immediately post plating (pure neuronal cultures) or
on DIV4 (mixed cultures). Cultures were utilized as indicated between DIV3 and
17, and were fed with the above described appropriate growth medium on DIV4.
Before experimentation cells were removed from growth medium and washed and
placed in a minimal deﬁned medium63 containing 10% minimum essential media
(Life Technologies Ltd) and 90% Salt-Glucose-Glycine (SGG) medium, which is
comprised of 114mM NaCl, 0.219% NaHCO3, 5.292mM KCl, 1mM MgCl2, 2mM
CaCl2, 10mM HEPES, 1mM Glycine, 30mM Glucose, 0.5mM sodium pyruvate,
0.1% Phenol Red; osmolarity 325mosm l 1) for at least 3 h. When cultures were
used 4DIV14, a 1:1 replacement of conditioned media with fresh growth media,
which lacked serum but was supplemented with glucose (10mM), was conducted
on DIV9 and 12. On DIV14, SGG supplemented with Insulin-Transferrin-
Selenium was used as the replacement media.
Establishment and maintenance of the hESC lines H9 and HUES9 (Harvard
University, Cambridge, MA, USA) are as previously described41. Brieﬂy, hESC lines
were cultured and regularly passaged on a feeder layer consisting of irradiated
mouse embryonic ﬁbroblasts. The neuralization and differentiation of NPCs into
neurons and astrocytes followed our established protocols21,22,41. Brieﬂy, human
PSCs were neurally converted (to NPCs) in suspension in chemically deﬁned
medium as described21,22. The media were changed to Base media (A-DMEM/F12,
1% P/S, 1% Glutamax, 1% N2), 0.4% B27, 2.5 ngml 1 FGF2 upon observation of
radially organized structures in neurospheres (10–21 days) and plated on Laminin
(Sigma)-coated tissue culture plates (Nunc) a week later. Neural rosettes were
mechanically isolated, dissociated with Accutase (Sigma) and 20–40 k cells were
plated in one Laminin-coated well of a 96-well plate in proliferation media (Base
media, 0.1% B27, 10 ngml 1 FGF2 and 10 ngml 1 EGF where stated). aNPCs
were grown to high density before passaging 1:2 with Accutase on laminin-coated
plates until passage 5–6 and maintained on 1:100 Reduced-growth factor Matrigel
(BD Biosciences)-coated plates thereafter. For neuronal differentiation, NPCs were
plated in default media (A-DMEM/F12, 1% P/S, 0.5% Glutamax, 0.5% N2, 0.2%
B27, 2 mgml 1 Heparin (Sigma)) on poly-D-lysine (Sigma), laminin (Sigma),
ﬁbronectin (Sigma) and Matrigel-coated coverslips for differentiation and fed twice
a week. Default media were supplemented with 10 mM forskolin (Tocris) in weeks
2 and 3. From week 4 onwards, forskolin was removed and default media were
supplemented with 5 ngml 1 brain-derived neurotrophic factor and 5 ngml 1
glial-derived neurotrophic factor. For astrocytic differentiation, NPCs were plated
in modiﬁed basal plating medium supplemented with BMP2 and BMP4 (R&D) at
10 ngml 1 and Leukemia Inhibitory Factor (Sigma) at 20 ngml 1.
Transfection and plasmids. Neuronal transfections were carried out using
Lipofectamine 2000 (2.33 ml per well, 1 mgml 1, Life Technologies Ltd) on DIV 3,
4 and 8 neurons. For neurons subject to oxygen glucose deprivation (OGD),
transfections were carried out in a trophically deprived transfection medium (TMo,
90% SGGþ 10% minimum essential media63). Non-OGD-related transfections
were carried out in normal transfection medium (TMits, TMo plus an Insulin-
Transferrin-Sodium Selenite Media Supplement). As reported previously, the
transfection efﬁciency for this protocol is approximately 5% for mixed cultures,
with 99% of the total transfected cells being neuronal in nature, as determined by
NeuN staining19. Constructs were co-transfected with peGFP in order to identify
successfully transfected cells. To ensure that GFP-positive neurons also express the
plasmid of interest, a favourable ratio was used (enhanced GFP-encoding plasmid
(pEGFP)/plasmid of interest, 1:2), as previously validated in the case of RFP-
encoding plasmid (pRFP)28. In all experimental comparisons, the amount of DNA
transfected per plasmid of interest as well as the total amount of DNA from all
plasmids (0.6–0.7 mg cDNA per well) was identical, with control plasmid being
utilized to balance amounts where required. Transfections were carried out using
Lipofectamine as previously described63, with cells incubated with transfection
mixture for 3 h before removal and transfer back to pre-transfection incubation
medium. Transfections designed for morphological assessment of neurite
outgrowth were performed at a lower dilution (1/16 of the normal full strength,
diluted in TMits) in order to reduce the total number of transfected cells. This
enabled accurate tracking of neurite projections from a single cell despite the high
density of the culture. The diluted DNA/lipofectamine transfection mixture was left
on for 3 h as with other full-strength transfections. For transfections on younger
neurons (DIV3–4), cells were returned to growth medium, and fed on DIV 4
following the termination of the transfection protocol as usual. Neurons were then
assessed on the indicated day as appropriate. In all instances the utilized control
plasmid was b-globin, referred to as control plasmid (here and throughout).
Plasmids expression was conﬁrmed (Supplementary Fig. 4d) and
have been previously described: pEF-Nrf2 (ref. 64), M50 Super 8x TOPFlash65,
pcDNA3-S33Y b-catenin-Flag66, pcDNA3-EGFP-Rac1-Q61L-myc, b-catenin-
ARM-myc67, Rac N17-myc68, pCDNA3-Jnk1a1 (ref. 69), NRX-RNAi in pSuper
and control-RNAi in pSuper26, Grx1-roGFP29, DVl1-HA25. The PSD-95-YFP
vector was kindly provided by Noboru Komiyama.
Electrophysiological recording and analysis. Coverslips containing cortical
DIV4–17 neurons were transferred to a recording chamber perfused (at a ﬂow rate
of 3–5mlmin 1) with an external recording solution composed of (in mM):
150 NaCl, 2.8 KCl, 10 HEPES, 2 CaCl2, 1 MgCl2, 10 glucose, 0.1 glycine and 0.002
strychnine, pH 7.3 (320–330mOsm). Patch-pipettes were made from thick-walled
borosilicate glass (Harvard Apparatus, Kent, UK) and ﬁlled with a K-gluconate-
based internal solution containing (in mM): 155 K-gluconate, 2 MgCl2,
10 Na-HEPES, 10 Na-PiCreatine, 2 Mg2-ATP and 0.3 Na3-GTP, pH 7.3
(300mOsm). To ensure sufﬁcient voltage-clamp of EPSCs, QX-314 (5mM) was
included in the internal solution to block voltage-gated conductances. Electrode
tips were ﬁre-polished for a ﬁnal resistance ranging between 5 and 10MO.
Currents were recorded at room temperature (21±2 C) using either an Axopatch-
1C or Axon Multiclamp 700B ampliﬁer (Molecular Devices). Neurons were
voltage-clamped at –60mV, and recordings were rejected if the holding current
was greater than –100 pA or if the series resistance drifted by more than 20% of its
initial value (o30MO). Whole-cell currents were analysed using WinEDR v3.2
software (John Dempster, University of Strathclyde, UK). To measure AMPA
receptor-mediated currents, 50 mM S-AMPA (Tocris) was applied for 5–10 s to
reach a steady-state plateau, washed out for 1–2min, then re-applied to elicit a
second response. The same procedure was used to acquire whole-cell NMDAR
currents (100 mM NMDA, Tocris Bioscience), except using Mg2þ -free external
recording solution in which MgCl2 was substituted with 2mM NaCl. All currents
were quantiﬁed as a 1 s average of the steady-state plateau minus the baseline at the
second agonist application, and normalized to the cell capacitance. Analysis of
EPSC areas was carried out in OriginLab. mEPSC frequencies and amplitudes were
analysed using MiniAnalysis (Synaptosoft) with the detection threshold set at
–5 pA. To be included for analysis, mEPSCs needed to possess a monotonic rise
and an exponential decay. Overall mEPSCs recorded from globin or Nrf2-trans-
fected cells had mean 10–90% rise times of o1.5ms and mean decay time con-
stants of o3ms.
OGD insult and cell fate tracking. DIV 7 neurons were transfected with either
pEF-Nrf2 or control plasmid, plus peGFP. On DIV9, GFP-expressing neurons were
imaged using a Leica AF6000 LX imaging system and DFC350 FX digital camera,
and their locations mapped using the Leica ‘Mark and Find’ software application.
Once GFPþ neurons were identiﬁed, imaged and plate/well locations saved,
they were returned to the incubator to re-equilibrate. Following a 3-h period of
equilibration, neurons were then exposed to 3 h OGD. Cells were washed and
incubated in a glucose-free, balanced salt solution (SGG with mannitol substituted
for glucose), previously degassed with 95% N2–5% C02 and placed in an anoxic
modular incubator chamber for 3 h (as compared with cells washed and incubated
in normoxic glucose-containing media). After 18–20 h (DIV 10), saved plate and
well locations were reloaded and images of the same cells were captured. Cell death
was assessed by counting the number of surviving GFPþ neurons pre- and
post- exposure to OGD. The user was blind during both image capture and cell
death analysis. In the vast majority of cases, neuronal death was easily identiﬁable
by the replacement of a healthy GFP-expressing cell with the presence of
fragmented neurites and ﬂuorescent cell debris. Cell death is presented as the
percentage of dead neurons/total post-OGD. Approximately 125 neurons were
monitored for each plasmid across four independent experiments.
Peroxide-induced cell death. Cultures were transferred to TMo for at least 3 h
before the start of the experiment (DIV as indicated). Cells were then treated with
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H2O2 (dose as indicated) and cell death determined 24 h later via ﬁxation with 4%
formaldehyde and nuclear staining with 4-,6-diamidino-2-phenylindole (DAPI).
As previously described28, images were captured and cell death quantiﬁed using an
automated technique created in Image J, which takes advantage of the large
difference in the nuclear size of living or dead cells. The automated system then
yields the number of dead versus living cells, enabling the user to calculate the
number of dead cells as a percentage of the total cell population. For DAPI-assisted
automated quantiﬁcation, cells were imaged under the  10 objective, allowing
B1,000 cells to be imaged at a time, with at least 12 images per treatment, allowing
approximately 12,000 cells to be quantiﬁed per experiment, in at least three
independent experiments. During both image capture and image quantiﬁcation,
the user was blind.
Morphological assessment of neurite branching. Neurons were transfected with
efGFP plus plasmid(s) of interest on DIV3/4 and left until DIV 4/7, whereupon
they were ﬁxed, stained (as described in immunoﬂuorescence below) and then
imaged at  20 for morphological analysis. Images were subjected to Sholl analysis,
as well as measurement of dendritic length and branch tip number, as facilitated by
the use of Image J software. Sholl analysis provides an assessment of dendritic
arborization and branch complexity via quantiﬁcation of the number of inter-
secting branch points across concentric circles spaced at speciﬁc distances from the
soma. Sholl analysis parameters were as follows: origin of the concentric radii was
set at the midpoint of the longest axis of the soma, starting radius: 10 mm, ending
radius: 170 mm, radius step size: 10 mm. Dendritic length represents the total
summed length of all dendrite branches present. Branch tip number refers to the
sum total of all terminal branch tips in a given neuron. In general, an average of
eight to ten neurons were quantiﬁed for Scholl analysis, dendritic length and
branch tip number for each investigated condition in a given experiment. Counts
for the eight to ten cells were then averaged per biological replicate, with at least
three replicates quantiﬁed in total.
PSD-95 density analysis and quantiﬁcation. DIV 4 neurons were transfected
with the plasmid of interest plus YFP-tagged PSD-95, as described above. On
DIV8, neurons were washed twice with pre-warmed TMO (to eliminate issues of
autoﬂuorescence associated with Neurobasal-A medium containing growth med-
ium) and images of live PSD-95 expressing neurons were captured at  20. PSD-95
density analysis was then performed on captured images using ImageJ software
(Wayne Rasband, US National Institutes of Health, Bethesda, MD, USA). The use
of immunostaining with antibodies against PSD-95 was deemed undesirable as
staining intensity was too high to accurately separate distinct PSD-95 puncta. Live
imaging of endogenous YFP signals from transfected YFP-tagged PSD-95 was
optimal. Because of the impact on Nrf2 expression on dendritic branching,
quantiﬁcation of secondary dendritic branches was not always possible. In an effort
to maintain consistency, the number of PSD-95 puncta along the full length of one
dendritic branch (including primary and secondary sections) was totalled and then
divided by the total length of the branch of interest. This density is presented as the
total number of PSD-95 puncta per 100 mm, for simplicity. At least eight dendritic
sections from independent cells were quantiﬁed per condition, with at least three
biological replicates throughout all experiments.
RNA isolation, reverse transcription (RT)–PCR and qPCR. RNA was isolated
using the Roche High Pure RNA Isolation Kit (including optional DNase treat-
ment), according to the manufacturer’s instructions (Roche). For quantitative PCR
(qPCR), cDNA was synthesized from 1 to 3 mg RNA using the Roche Transcriptor
First Strand cDNA Synthesis Kit, according to the manufacturer’s instructions.
cDNA was then stored at  20 C or immediately diluted (equivalent of 6 ng of
initial RNA per 15ml qPCR reaction, per gene of interest) for real-time PCR in a
Stratagene Mx3000P QPCR System (Agilent Technologies), using the Roche FS
universal SYBR Green MasterRox mix, according to the manufacturer’s instruc-
tions. The required amount of template was mixed with water, SYBR Green
MasterRox mix and forward and reverse primers (200 nM each ﬁnal concentration)
to the required reaction volume. Technical replicates as well as no template and no
RT negative controls were included and at least three biological replicates were
studied per study. Primer sequences are described in Supplementary Table 1. The
qRT-PCR cycling programme was 10min at 95 C; 40 cycles of 30 s at 95 C, 40 s at
60 C with detection of ﬂuorescence and 30 s at 72 C; 1 cycle (for dissociation
curve) of 1min at 95 C and 30 s at 55 C with a ramp up to 30 s at 95 C (ramp
rate: 0.2 C s 1) with continuous detection of ﬂuorescence on the 55–95 C ramp.
Data were analysed using the MxPro qPCR analysis software (Stratagene), with 18 s
or GAPDH expression utilized as an internal normalizer. For murine experiments
involving TSA application, expression of the housekeeping gene RPL13A, which
encodes the ribosomal highly basic 23-kDa protein, was used as the internal
standard for normalization, as RPL13A expression is unaffected by TSA
application70.
Chromatin immunoprecipitation. ChIP was performed using the MAGnify
Chromatin Immunoprecipitation System (Life Technologies Ltd), according to the
manufacturer’s instructions. Brieﬂy 2 60mm dishes were used per treatment
(B4.5 106 cells). Cells were washed once with pre-warmed media and then
incubated in media plus paraformaldehyde (1% ﬁnal concentration) at room
temperature for 8min to enable protein/DNA cross-linking. Fixation was then
quenched by addition of glycine (ﬁnal concentration 125mM, 5min). Dishes were
then transferred to ice, and cells washed and resuspended in ice-cold DNAse-free
PBS, using plastic scrapers. Cell lysates were then transferred to microcentrifuge
tubes and spun at 200g for 10min to pellet. Following removal and discard of the
supernatant, the cell pellet was resuspended (via mild pulsing on the vortex) in lysis
buffer plus protease inhibitors, and left on ice for 5min before being sonicated
using a Branson 450 Soniﬁer (ﬁve 20 s pulses at 10% power, 15 s intervals between
pulses), to yield chromatin fragments of roughly 200–500 bp in length (as deter-
mined by sonication optimization test experiments). At this stage, a fraction of
each sample was kept aside as input control. For immunoprecipitation, a portion of
the sheared chromatin sample was diluted tenfold with dilution buffer and then
immunoprecipitated via 2 h incubation with Dynabeads Protein A/G pre-coupled
to either rabbit anti-acetyl-Histone H3 antibodies (AcH3, 2.5 mg per sample, Merck
Millipore) or normal IgG. Lysine 14 acetylation is a marker of genes being actively
transcribed into RNA, thus immunoprecipitation with anti-AcH3 antibodies allows
an assessment of the relative activity at a promoter of interest. Following extensive
washing with immunoprecipitation buffers 1 and 2, cross-linking was reversed via
heat and reverse crosslinking buffer. DNA was puriﬁed from the samples by DNA
puriﬁcation magnetic beads before elution in DNA elution buffer. The relative
association of AcH3 to the Nrf2 or b actin promoters was then quantitatively
assessed in input control and immunoprecipitated samples via real-time qPCR
(as described above) using validated primers directed against the mouse Nrf2 and
b-actin promoter regions (for sequences see Supplementary Table 1). In all
instances, samples were normalized to their respective non-immunoprecipitated
input controls.
Fluorescent-activated cell sorting. All procedures were authorized under a UK
Home Ofﬁce approved project licence and adhered to regulations speciﬁed in the
Animals (Scientiﬁc Procedures) Act (1986). Cortical cells obtained from 12- to
14-week-old adult CD1 male mice were processed essentially as described in ref. 20.
Brieﬂy, mice were culled via decapitation, cortices quickly removed in Hibernate A
(Hib A, Life Technologies Ltd) and then minced on ice before incubation in
Accutase (Merck Millipore) for 30min at 4 C on a rotator. After centrifugation,
cortices were resuspended in Hib A and homogenized with a ﬁre-polished Pasteur
pipette. Debris was removed via ﬁltration through a 40 mM ﬁlter and three-step
Percoll gradient. Cell pellets were resuspended in Hib A and an equal amount of
cold absolute ethanol was added. Cells were then left on ice for 15min with
occasional inversion, before centrifugation and resuspension in RNAse/DNAse-
free PBS and incubation with an anti-NeuN primary antibody (6:1,000, Merck
Millipore) for 30min at 4 C on a rotator. Cells were washed, resuspended in
RNAse/DNAse-free PBS containing Cy3-donkey anti-mouse secondary antibody
and left to rotate for 15min at 4 C (1:200, Stratech Scientiﬁc Limited), before
washing and resuspension in RNAse/DNAse-free PBS. Cells were brieﬂy incubated
with DNA-binding dye 7AAD (Life Technologies Ltd) to identify nucleated events
and facilitate gating and sort parameters, before sorting using a FACS-Jazz cell
sorter (BD Biosciences). All non-7AADþ events were omitted as they were
considered non-nuclear. To establish the normal light scattering characteristics of
the gated population (7AADþ events), a sample that had not been exposed to
antibodies was ﬁrst sorted. Following this a sample that had only been exposed to
the Cy-3-conjugated secondary antibody was sorted to establish the maximum
threshold for nonspeciﬁc binding. Following establishment of the appropriate
gating thresholds, experimental samples were sorted into two tubes based on
their emission proﬁle as either NeuNþ /7AADþ or NeuN /7AADþ (see
Supplementary Fig. 1e). A total of 300 K NeuNþ and 300K NeuN cells were
collected per repeat. Purity testing was done for each n to ensure sorting accuracy,
sorted samples consistently showed 498% purity proﬁles (see Supplementary Fig
1e). RNA was immediately isolated as describe above using the Roche High-Pure
RNA Isolation Kit. Following RNA isolation and cDNA synthesis, expression of
cell-speciﬁc gene markers was assessed by qRT–PCR to conﬁrm enrichment of
neuronal and non-neuronal genes in appropriate NeuNþ and NeuN FACS
populations.
Reporter assays. A ﬁreﬂy luciferase-based reporter gene construct (M50 Super 8x
TOPFlash, a Beta-catenin reporter with TCF/LEF sites upstream of a luciferase
reporter) was transfected along with a renilla expression vector (pTK-RL), and
where relevant, other expression vectors of interest on DIV8. Neurons were
stimulated with H2O2 48 h after transfection (for 16 h). Luciferase assays were
performed using the Dual Glo assay kit (Promega) with Fireﬂy luciferase-based
reporter gene activity normalized to the Renilla control (pTK-RL plasmid) in
all cases. All luminescent assays were performed on a FLUOstar OPTIMA
(BMG Labtech). Light collection time and gain were set such that counts were
substantially lower than the maximum level collectable.
Immunoﬂuorescence. Cells were ﬁxed with formaldehyde, washed with PBS,
permeabilized with PBSþNP-40 (Life Technologies Ltd) and washed again before
overnight rotating incubation with primary antibodies diluted in PBS at 4 C. The
following day, cells were washed and antibody binding visualized via biotinylated
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secondary antibody/ﬂuorophore-conjugated streptavidin. Where required, nuclei
were counter-stained with DAPI. In all instances, non-saturating images were
captured on a Leica AF6000 LX imaging system. Employed primary antibodies
include: rabbit anti-Hmox1 (1:1,000, Stressgen Biotechnologies), mouse anti-GFAP
(1:400, Sigma), rabbit anti-GFP (1:750, Life Technologies Ltd), Milli-Mark
neuronal antibody cocktail (Millipore, 1:500) and Anti-Nrf2 (Cell Signaling).
To measure Hmox1 immunoﬂuorescence intensity, non-saturating images at  20
were captured using the Leica AF6000 LX imaging system with DFC350 FX digital
camera. Fluorescence intensity was quantiﬁed using Image J software. Fluorescence
intensity was quantiﬁed for each cell across four or ﬁve ﬁelds, with each ﬁeld
containing 10–18 cells. To ensure consistency, settings were maintained across all
conditions in a given experiment. Background intensity was subtracted from cel-
lular intensity, and resulting values of approximately 70 cells per condition were
averaged and normalized to control.
Western blotting. For protein extraction experiments, cells were cultured in
35mm dishes. To minimize the chance of post-translational modiﬁcations during
the harvesting process, cells were immediately lysed in  1.5 sample buffer (1.5M
Tris (pH 6.8); 15% glycerol; 3% SDS; 7.5% b-mercaptoethanol; bromophenol blue
0.0375%) and boiled at 100 C for 10min. Approximately 30 mg of protein was
loaded per lane and the gel then subjected to gel electrophoresis and western
blotting using the Xcell Surelock system with precast gradient gels (4–20%,
Life Technologies Ltd), according to the manufacturer’s instructions. Gels were
blotted onto polyvinylidene diﬂuoride membranes, and blocked for 1 h at room
temperature with 5% (w/v) non-fat dried milk in TBS with 0.1% Tween-20.
Membranes were incubated overnight at 4 C with primary antibodies diluted in
the blocking solution: Anti-cJun (1:1,000, Cell Signalling), Anti-pSer73-cJun
(1:1,000, Cell Signalling), Anti-Nrf2 (1:1,000, Cell Signaling), anti-b-actin (1:2,000,
Sigma). For visualization of western blots, HRP-based secondary antibodies were
used followed by chemiluminescent detection on Kodak X-Omat ﬁlm. Appropriate
exposures were taken such that bands were not saturated. Where required a
stripping agent was utilized to enable detection of the same blot with a second
antibody, as achieved through the use of Re-Blot Plus Stripping Solution
(Millipore). Western blots were analysed by digitally scanning the blots, followed
by densitometric analysis (ImageJ). Signals were normalized to either amounts of
p-c-Jun relative to cJun, or to amounts of Nrf2 relative to b-actin as loading
control. For ﬁgure preparation of example western blots, linear adjustment of
brightness/contrast was applied (Photoshop) equally across the entire image, taking
care to maintain some background intensity.
Statistical analysis. Paired t-tests were used to compare non-independent data
pairs, whereas Student’s t-tests were utilized when the two groups were not related.
For studies employing multiple testing, we used a one- or two-way analysis of
variance followed by Tukey’s or Bonferroni’s post-hoc test as appropriate. For all
tests signiﬁcance was set at *Po0.05. Analysis of cell death, dendritic morphology
and PSD-95 puncta density was performed blind to the mouse genotype or other
experimental history (drug treatment, plasmid transfected and so on). Error bars
represent standard error of the mean.
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